Evaluation of two nonisotopic immunoassays for determination of glutamic acid decarboxylase and tyrosine phosphatase autoantibodies in serum

Clinical Chemistry

Volumn 50, Issue 8, 2004, Pages 1378-1382

  Palomer, Xavier ^a   Mauricio, Dídac ^a,b   Rodríguez Espinosa, José ^a   Zapico, Edgar ^a   Mayoral, Carme ^a   González Sastre, Francesc ^a,c   De Leiva, Alberto ^a,c   Blanco Vaca, Francisco ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMATE DECARBOXYLASE AUOTANTIBODY; PHOSPHOTYROSINE; PHOSPHOTYROSINE AUTOANTIBODY; PROTEIN TYROSINE PHOSPHATASE LIKE PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASSAY; BINDING AFFINITY; BLOOD SAMPLING; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; FLUOROMETRY; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREDICTION; RADIOBINDING ASSAY; TIME RESOLVED IMMUNOFLUOROMETRY ASSAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROIMMUNOASSAY; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; PROTEIN-TYROSINE-PHOSPHATASE; RADIOLIGAND ASSAY; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 3242774581     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.031799     Document Type: Article

References (12)

1. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 2001;108:1247-52.
2. Ankelo M, Westerlund-Karlsson A, Ilonen J, Knip M, Savola K, Kankaanpää P, et al. Time-resolved fluorometric assay for detection of autoantibodies to glutamic acid decarboxylase (GAD65). Clin Chem 2003;49:908-15.
3. Westerlund-Karlsson A, Suonpää K, Ankelo M, Ilonen J, Knip M, Hinkkanen A. Detection of autoantibodies to protein tyrosine phosphatase-like protein IA-2 with a novel time-resolved fluorometric assay. Clin Chem 2003;49:916-23.
4. Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult). Diabetes Care 2001;24:1460-7.
5. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes. Diabetes 1998;47:1857-66.
6. Leslie RDG, Atkinson MA, Notkins AL. Autoantigens IA-2 and GAD in type I (insulin-dependent) diabetes. Diabetologia 1999;42:3-14.
7. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
8. Bingley PJ, Bonifacio E, Mueller PW, Participating Laboratories. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003;52:1128-36.
9. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37:344-9.
10. Brooking H, Ananieva-Jordanova R, Arnold C, Amoroso M, Powell M, Betterle C, et al. A sensitive non-isotopic assay for GAD65 autoantibodies. Clin Chim Acta 2003;331:55-9.
11. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices: approved guideline. NCCLS document EP5-A. Wayne, PA: NCCLS, 1999;19.
12. Solberg HE. Statistical treatment of collected reference values and determination of reference limits. In: Gräsbeck R, Alström T, eds. Reference values in laboratory medicine. Chichester: John Wiley & Sons, 1981:193-205.